CD4 and neoplasm: In turn, this underlined the in vitro survival of CD4+ subsets of activated tumor-derived Jurkat T cells (Table S2) and their proinflammatory secretion (Table S3) during 14-day contact with rough CaP coating bearing a negative sign of ZP (Figure 4b,c).